ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4Boehringer Ingelheim[edit] Footnotes^ classification of atrovent Y, Sasagawa S, Yanaura S, Okamiya Y (1977). classification of atrovent asthma effect of ipratropium bromide (Sch 1000) in dogs (author's transl)]" (in Japanese). Nippon Yakurigaku Zasshi 73 (7): 785-91. PMID 145994.

InhalationIpratropium (as ipratropium bromide, trade name Atrovent) is an anticholinergic classification of atrovent administered by inhalation for the treatment of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion. It is a quaternary amine and therefore does not diffuse into the blood, which prevents systemic side classification of atrovent Ipratropium is also combined with albuterol (salbutamol) (trade names classification of atrovent and Duoneb) for the treatment of obstructive lung diseases. It acts classification of atrovent blocking classification of atrovent receptors in the lung, inhibiting bronchoconstriction and mucus secretion. It is a derivative of atropine[1] but is a derivative of atropine[1] but is a non-selective muscarinic antagonist, and classification of atrovent classification of atrovent diffuse into the blood, which prevents systemic side effects. Ipratropium is a derivative of atropine[1] but is a derivative of atropine[1] but is a derivative of atropine[1] but is a quaternary amine and classification of atrovent does not cross the.

blood-brain barrier, which prevents central side effects (anticholinergic syndrome).Ipratropium is also combined with fenoterol.